High LDL Cholesterol and Dementia: What the Newest Research Shows

It's already on your radar for heart disease. In 2024, it officially joined the list of modifiable dementia risk factors too.

Why did cholesterol get added to the dementia risk factor list?

The 2024 update to the Lancet Commission's report expanded its list of modifiable risk factors from 12 to 14, adding high LDL cholesterol and vision loss based on newer accumulated evidence.

The Lancet Commission on dementia prevention, intervention, and care periodically reviews the global research and updates which modifiable factors have enough supporting evidence to be included in its official list. In 2024, high LDL cholesterol was added specifically because of growing evidence connecting midlife cholesterol levels to later dementia risk — joining longer-established factors like hearing loss, education, blood pressure, and smoking. The Commission estimates that high LDL cholesterol in midlife accounts for roughly 7% of dementia cases worldwide, a meaningful share for a single modifiable factor.

Why would cholesterol affect the brain?

LDL cholesterol contributes to vascular damage and is implicated in the buildup of amyloid plaques, connecting it to both the vascular and Alzheimer's-specific pathways of dementia.

Cholesterol's link to heart disease and stroke is long established, and vascular health is directly connected to brain health — reduced blood flow and small vessel damage from high cholesterol can contribute to vascular dementia specifically. There's also research connecting cholesterol metabolism to amyloid-beta, the protein that forms the plaques characteristic of Alzheimer's disease, suggesting a more direct biological link beyond just vascular damage. Researchers are still working out the precise mechanisms, but the connection appears to run through more than one pathway.

Does treating high cholesterol actually reduce dementia risk?

A large meta-analysis found statin use was associated with a lower risk of dementia compared to leaving high cholesterol untreated — encouraging evidence, though not proof for any individual person.

A meta-analysis pooling 36 cohort studies found that statin use was associated with reduced risk of all-cause dementia, and specifically Alzheimer's disease, compared to people with untreated high cholesterol. Researchers note statins may help through more than just lowering cholesterol — they're also thought to have anti-inflammatory and antioxidant effects that could independently benefit brain health. As with most large observational findings, this is a strong association rather than airtight proof for any one person, but it adds meaningfully to the case for actively managing cholesterol in midlife rather than leaving it untreated.

Why timing matters

The strongest associations show up with midlife cholesterol levels, roughly ages 40 to 65, rather than cholesterol measured later in life.

The Lancet Commission's framework organizes risk factors by the life stage where intervention matters most, and high LDL cholesterol is categorized as a midlife factor. This tracks with a broader pattern in dementia prevention research: several vascular risk factors (blood pressure, cholesterol, diabetes) appear to do more damage when they're elevated for years during midlife than when they first appear later in life, likely because of cumulative vascular effects over time. This is one more reason cholesterol management in your 40s, 50s, and early 60s is worth taking seriously, beyond the more immediate heart-disease framing most people already know.

What this means for your family

For most families, this doesn't require a new intervention — it means the existing cholesterol management conversation with a doctor now has an additional, meaningful reason behind it.

• If a family member (including yourself, if you're managing your own midlife health alongside caregiving) has known high LDL cholesterol, this is one more reason to take treatment seriously rather than deprioritizing it.
• Ask a doctor about your own or a loved one's LDL levels at the next checkup if it hasn't been discussed recently, framed around both heart and brain health.
• If a statin has been recommended but not started, or started and then stopped, this research is worth factoring into that conversation.
• Lifestyle factors that affect LDL — diet, exercise, weight — support both cardiovascular and potentially cognitive health simultaneously, which can be a helpful, less siloed way to think about prevention.